|
OMIM |
Link |
Information gain |
01 |
|
RNASE3
|
[NCBI]
|
0.0164616
|
|
|
QPD
|
[NCBI]
|
0.00635088
|
|
|
stomatocytosis i
|
[NCBI]
|
0.00591567
|
|
|
LKE
|
[NCBI]
|
0.00192188
|
|
|
lipoprotein types--ld system
|
[NCBI]
|
0.00192188
|
|
|
hennekam lymphangiectasia-lymphedema syndrome
|
[NCBI]
|
0.00192188
|
|
|
CDAN2
|
[NCBI]
|
0.00156855
|
|
|
GPS
|
[NCBI]
|
0.00134104
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.00120565
|
|
|
lymphangiectasia, intestinal
|
[NCBI]
|
0.00107966
|
|
|
r binder deficiency with lactoferrin deficiency
|
[NCBI]
|
0.00107966
|
|
|
RNASE2
|
[NCBI]
|
0.00100956
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.000986568
|
|
|
zinc, elevated plasma
|
[NCBI]
|
0.000912844
|
|
|
CF
|
[NCBI]
|
0.000884551
|
|
|
ALB
|
[NCBI]
|
0.000660349
|
|
|
EL1
|
[NCBI]
|
0.000644038
|
|
|
DHS
|
[NCBI]
|
0.000618515
|
|
|
MPO
|
[NCBI]
|
0.000609668
|
|
|
AHSG
|
[NCBI]
|
0.000582203
|
|
|
FCAS
|
[NCBI]
|
0.000553261
|
|
|
HRG
|
[NCBI]
|
0.00052499
|
|
|
muckle-wells syndrome
|
[NCBI]
|
0.000459392
|
|
|
EPB42
|
[NCBI]
|
0.000454275
|
|
|
CINCA
|
[NCBI]
|
0.000422814
|
|
|
HP
|
[NCBI]
|
0.000362793
|
|
|
TF
|
[NCBI]
|
0.000337175
|
|
|
BSG
|
[NCBI]
|
0.000320199
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
0.000308541
|
|
|
RHAG
|
[NCBI]
|
0.000269027
|
|
|
GC
|
[NCBI]
|
0.000263933
|
|
|
PCI
|
[NCBI]
|
0.000250474
|
|
|
BPI
|
[NCBI]
|
0.000244498
|
|
|
PRG2
|
[NCBI]
|
0.000231785
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
0.000228215
|
|
|
SPS
|
[NCBI]
|
0.000225342
|
|
|
LBP
|
[NCBI]
|
0.000219578
|
|
|
ANGPTL4
|
[NCBI]
|
0.000219213
|
|
|
VEGF
|
[NCBI]
|
0.000200922
|
|
|
xh antigen
|
[NCBI]
|
0.000196322
|
|
|
SGD
|
[NCBI]
|
0.000190048
|
|
|
PROZ
|
[NCBI]
|
0.000189253
|
|
|
NPY
|
[NCBI]
|
0.000178918
|
|
|
LAD
|
[NCBI]
|
0.00017694
|
|
|
EPB72
|
[NCBI]
|
0.000164163
|
|
|
HS
|
[NCBI]
|
0.000160414
|
|
|
HIDS
|
[NCBI]
|
0.000156098
|
|
|
EPB49
|
[NCBI]
|
0.000154501
|
|
|
PRL
|
[NCBI]
|
0.000153742
|
|
|
EPB41
|
[NCBI]
|
0.000152653
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000142953
|
|
|
CCK
|
[NCBI]
|
0.000142522
|
|
|
obesity
|
[NCBI]
|
0.000140627
|
|
|
AD
|
[NCBI]
|
0.000132247
|
|
|
RHN
|
[NCBI]
|
0.000131908
|
|
|
A1BG
|
[NCBI]
|
0.000128745
|
|
|
TNA
|
[NCBI]
|
0.000128745
|
|
|
ERAF
|
[NCBI]
|
0.000128602
|
|
|
F5F8D
|
[NCBI]
|
0.000126633
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
0.000126427
|
|
|
aHUS
|
[NCBI]
|
0.000122914
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
0.000121931
|
|
|
regeneration-associated serpin-1
|
[NCBI]
|
0.000119825
|
|
|
THB
|
[NCBI]
|
0.000119825
|
|
|
neuropathy, with paraprotein in serum, cerebrospinal fluid and urine
|
[NCBI]
|
0.000119825
|
|
|
blood group--public systems
|
[NCBI]
|
0.000119825
|
|
|
OK
|
[NCBI]
|
0.000119825
|
|
|
factor v and factor viii, combined deficiency of, with normal protein c and protein c inhibitor
|
[NCBI]
|
0.000119825
|
|
|
CDG2G
|
[NCBI]
|
0.000119825
|
|
|
RDX
|
[NCBI]
|
0.000114313
|
|
|
DEFB1
|
[NCBI]
|
0.000114135
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
0.000113835
|
|
|
VIP
|
[NCBI]
|
0.000113558
|
|
|
CP
|
[NCBI]
|
0.000112964
|
|
|
EGF
|
[NCBI]
|
0.000112772
|
|
|
PCNA
|
[NCBI]
|
0.000112397
|
|
|
TNF
|
[NCBI]
|
0.000109717
|
|
|
APOF
|
[NCBI]
|
0.000107032
|
|
|
LST1
|
[NCBI]
|
0.000106407
|
|
|
ADD1
|
[NCBI]
|
0.000103655
|
|
|
NAZC
|
[NCBI]
|
0.000102991
|
|
|
MMRN1
|
[NCBI]
|
0.000100536
|
|
|
complement factor h deficiency
|
[NCBI]
|
9.85261e-05
|
|
|
CRH
|
[NCBI]
|
9.66631e-05
|
|
|
CFHR1
|
[NCBI]
|
9.18467e-05
|
|
|
SERPINA6
|
[NCBI]
|
9.00948e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
8.83523e-05
|
|
|
normokalemic periodic paralysis
|
[NCBI]
|
8.83523e-05
|
|
|
pa polymorphism of alpha-2-globulin
|
[NCBI]
|
8.83523e-05
|
|
|
von willebrand disease, x-linked form
|
[NCBI]
|
8.83523e-05
|
|
|
KN
|
[NCBI]
|
8.83523e-05
|
|
|
hemolytic anemia with thermal sensitivity of red cells
|
[NCBI]
|
8.83523e-05
|
|
|
LCP1
|
[NCBI]
|
8.45547e-05
|
|
|
NLRP3
|
[NCBI]
|
8.27133e-05
|
|
|
TH
|
[NCBI]
|
8.22403e-05
|
|
|
DEFA5
|
[NCBI]
|
7.75243e-05
|
|
|
PLEK
|
[NCBI]
|
7.72398e-05
|
|
|
STOML2
|
[NCBI]
|
7.72398e-05
|
|
|
HCLS1
|
[NCBI]
|
7.72398e-05
|
|
|
SRN1
|
[NCBI]
|
7.65472e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
7.65472e-05
|
|
|
RP26
|
[NCBI]
|
7.65472e-05
|
|
|
BDNF
|
[NCBI]
|
7.62616e-05
|
|
|
TTR
|
[NCBI]
|
7.22566e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
6.89225e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
6.89225e-05
|
|
|
VRNI
|
[NCBI]
|
6.60455e-05
|
|
|
CFHR5
|
[NCBI]
|
6.52386e-05
|
|
|
protein z-dependent protease inhibitor precursor
|
[NCBI]
|
6.52386e-05
|
|
|
DEFA6
|
[NCBI]
|
6.52386e-05
|
|
|
ORM1
|
[NCBI]
|
6.50473e-05
|
|
|
PROS1
|
[NCBI]
|
6.46329e-05
|
|
|
h-y antigen receptor
|
[NCBI]
|
6.32834e-05
|
|
|
VASP
|
[NCBI]
|
6.29059e-05
|
|
|
CLC
|
[NCBI]
|
6.24401e-05
|
|
|
NKTR
|
[NCBI]
|
5.93079e-05
|
|
|
PF4
|
[NCBI]
|
5.84249e-05
|
|
|
PTH
|
[NCBI]
|
5.80024e-05
|
|
|
PZP
|
[NCBI]
|
5.75526e-05
|
|
|
MBP
|
[NCBI]
|
5.54028e-05
|
|
|
kindler syndrome
|
[NCBI]
|
5.51165e-05
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
5.51165e-05
|
|
|
PARK4
|
[NCBI]
|
5.51165e-05
|
|
|
ITIH4
|
[NCBI]
|
5.51009e-05
|
|
|
KTN1
|
[NCBI]
|
5.51009e-05
|
|
|
CFHR4
|
[NCBI]
|
5.51009e-05
|
|
|
CFTR
|
[NCBI]
|
5.43932e-05
|
|
|
AR
|
[NCBI]
|
5.38378e-05
|
|
|
ESD
|
[NCBI]
|
5.22564e-05
|
|
|
PXE
|
[NCBI]
|
5.20137e-05
|
|
|
HPP
|
[NCBI]
|
5.19687e-05
|
|
|
ITGAM
|
[NCBI]
|
5.18168e-05
|
|
|
PRG3
|
[NCBI]
|
5.14908e-05
|
|
|
PLEKHA2
|
[NCBI]
|
5.14908e-05
|
|
|
DEFA1
|
[NCBI]
|
5.01004e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
4.92314e-05
|
|
|
PARK1
|
[NCBI]
|
4.92314e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
4.92314e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
4.92314e-05
|
|
|
APOE
|
[NCBI]
|
4.70455e-05
|
|
|
myeloma, multiple
|
[NCBI]
|
4.68129e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
4.68129e-05
|
|
|
sarcoidosis
|
[NCBI]
|
4.68129e-05
|
|
|
KLK3
|
[NCBI]
|
4.55664e-05
|
|
|
CHS
|
[NCBI]
|
4.55131e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
4.4649e-05
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
4.4649e-05
|
|
|
VDR
|
[NCBI]
|
4.4639e-05
|
|
|
ACHE
|
[NCBI]
|
4.39296e-05
|
|
|
RHCE
|
[NCBI]
|
4.36776e-05
|
|
|
MG
|
[NCBI]
|
4.36694e-05
|
|
|
TG
|
[NCBI]
|
4.31456e-05
|
|
|
HPR
|
[NCBI]
|
4.30756e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
4.30756e-05
|
|
|
KTCN1
|
[NCBI]
|
4.26933e-05
|
|
|
PSD
|
[NCBI]
|
4.13092e-05
|
|
|
CDC42EP1
|
[NCBI]
|
4.13092e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
4.13092e-05
|
|
|
CDC42EP4
|
[NCBI]
|
4.13092e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
4.09108e-05
|
|
|
hemangioma-thrombocytopenia syndrome
|
[NCBI]
|
4.09108e-05
|
|
|
NGFB
|
[NCBI]
|
3.94014e-05
|
|
|
PLTP
|
[NCBI]
|
3.90642e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
3.77646e-05
|
|
|
A2M
|
[NCBI]
|
3.73702e-05
|
|
|
CAT
|
[NCBI]
|
3.69765e-05
|
|
|
ANGPTL2
|
[NCBI]
|
3.67315e-05
|
|
|
RHCG
|
[NCBI]
|
3.67315e-05
|
|
|
PDCD1LG2
|
[NCBI]
|
3.67315e-05
|
|
|
dent disease 1
|
[NCBI]
|
3.6363e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.62919e-05
|
|
|
CERK
|
[NCBI]
|
3.54323e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
3.50566e-05
|
|
|
PAPPA
|
[NCBI]
|
3.44688e-05
|
|
|
S100A8
|
[NCBI]
|
3.44688e-05
|
|
|
PLOSL
|
[NCBI]
|
3.38341e-05
|
|
|
CFHR3
|
[NCBI]
|
3.36028e-05
|
|
|
TSTA3
|
[NCBI]
|
3.36028e-05
|
|
|
EPX
|
[NCBI]
|
3.36028e-05
|
|
|
ANK2
|
[NCBI]
|
3.36028e-05
|
|
|
SLC4A1
|
[NCBI]
|
3.28034e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
3.26862e-05
|
|
|
RCDP1
|
[NCBI]
|
3.26862e-05
|
|
|
PSCD3
|
[NCBI]
|
3.12154e-05
|
|
|
NCR3
|
[NCBI]
|
3.12154e-05
|
|
|
CGL2
|
[NCBI]
|
3.05839e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
2.96171e-05
|
|
|
MPP1
|
[NCBI]
|
2.92844e-05
|
|
|
OSBP
|
[NCBI]
|
2.90835e-05
|
|
|
ITGB2
|
[NCBI]
|
2.81078e-05
|
|
|
MLLT7
|
[NCBI]
|
2.7664e-05
|
|
|
SPTB
|
[NCBI]
|
2.72826e-05
|
|
|
FOXO3A
|
[NCBI]
|
2.72826e-05
|
|
|
FMF
|
[NCBI]
|
2.64523e-05
|
|
|
PRDX2
|
[NCBI]
|
2.62691e-05
|
|
|
PFIC1
|
[NCBI]
|
2.62034e-05
|
|
|
AHR
|
[NCBI]
|
2.61107e-05
|
|
|
EPO
|
[NCBI]
|
2.6092e-05
|
|
|
PI
|
[NCBI]
|
2.58904e-05
|
|
|
ARHGAP15
|
[NCBI]
|
2.57442e-05
|
|
|
ATP6V1G2
|
[NCBI]
|
2.57442e-05
|
|
|
all1-fused gene from chromosome 1q
|
[NCBI]
|
2.57442e-05
|
|
|
FARP1
|
[NCBI]
|
2.57442e-05
|
|
|
cytokine-like protein c17
|
[NCBI]
|
2.57442e-05
|
|
|
killer-specific secretory protein, 37-kd
|
[NCBI]
|
2.57442e-05
|
|
|
PHLDA3
|
[NCBI]
|
2.57442e-05
|
|
|
PLEKHA4
|
[NCBI]
|
2.57442e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
2.57442e-05
|
|
|
STOML1
|
[NCBI]
|
2.57442e-05
|
|
|
LEAP2
|
[NCBI]
|
2.57442e-05
|
|
|
serum protein polymorphism m-158
|
[NCBI]
|
2.57442e-05
|
|
|
casein kinase ii-interacting protein 1
|
[NCBI]
|
2.57442e-05
|
|
|
solo gene
|
[NCBI]
|
2.57442e-05
|
|
|
TGM7
|
[NCBI]
|
2.57442e-05
|
|
|
platelet receptor for type iii collagen, 47-kd
|
[NCBI]
|
2.57442e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.56526e-05
|
|
|
SHH
|
[NCBI]
|
2.5495e-05
|
|
|
CHAC
|
[NCBI]
|
2.54455e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.50866e-05
|
|
|
CRC
|
[NCBI]
|
2.49897e-05
|
|
|
HSAN3
|
[NCBI]
|
2.47201e-05
|
|
|
AT
|
[NCBI]
|
2.44014e-05
|
|
|
CXCL10
|
[NCBI]
|
2.3957e-05
|
|
|
DEFB4
|
[NCBI]
|
2.3957e-05
|
|
|
PPBP
|
[NCBI]
|
2.3957e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
2.3957e-05
|
|
|
CLL
|
[NCBI]
|
2.33577e-05
|
|
|
ORM2
|
[NCBI]
|
2.2977e-05
|
|
|
SLC6A3
|
[NCBI]
|
2.28202e-05
|
|
|
MAG
|
[NCBI]
|
2.27975e-05
|
|
|
POMC
|
[NCBI]
|
2.25166e-05
|
|
|
SPN
|
[NCBI]
|
2.20866e-05
|
|
|
CNTF
|
[NCBI]
|
2.08929e-05
|
|
|
AFP
|
[NCBI]
|
2.04402e-05
|
|
|
GNRH1
|
[NCBI]
|
2.0202e-05
|
|
|
MCP
|
[NCBI]
|
2.00601e-05
|
|
|
APC
|
[NCBI]
|
1.92074e-05
|
|
|
CD
|
[NCBI]
|
1.88929e-05
|
|
|
HHC1
|
[NCBI]
|
1.88396e-05
|
|
|
PRTN3
|
[NCBI]
|
1.85695e-05
|
|
|
MPP4
|
[NCBI]
|
1.83646e-05
|
|
|
CDC42EP2
|
[NCBI]
|
1.83646e-05
|
|
|
DGKQ
|
[NCBI]
|
1.83646e-05
|
|
|
ARHGEF1
|
[NCBI]
|
1.83646e-05
|
|
|
vascular wall-linked protein
|
[NCBI]
|
1.83646e-05
|
|
|
PPIG
|
[NCBI]
|
1.83646e-05
|
|
|
PLEKHA5
|
[NCBI]
|
1.83646e-05
|
|
|
lymphocyte cytosol polypeptide, 49-kd
|
[NCBI]
|
1.83646e-05
|
|
|
PLEKHA3
|
[NCBI]
|
1.83646e-05
|
|
|
ABLIM1
|
[NCBI]
|
1.83646e-05
|
|
|
RHBG
|
[NCBI]
|
1.83646e-05
|
|
|
MMRN2
|
[NCBI]
|
1.83646e-05
|
|
|
PLEKHA6
|
[NCBI]
|
1.83646e-05
|
|
|
CDC42EP5
|
[NCBI]
|
1.83646e-05
|
|
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
|
[NCBI]
|
1.83646e-05
|
|
|
DEFA4
|
[NCBI]
|
1.83646e-05
|
|
|
lymphocyte cytosol polypeptide, 40-kd
|
[NCBI]
|
1.83646e-05
|
|
|
STOML3
|
[NCBI]
|
1.83646e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.78385e-05
|
|
|
CLU
|
[NCBI]
|
1.76224e-05
|
|
|
Ge
|
[NCBI]
|
1.74648e-05
|
|
|
DJS
|
[NCBI]
|
1.74421e-05
|
|
|
ACPP
|
[NCBI]
|
1.711e-05
|
|
|
WAS
|
[NCBI]
|
1.67671e-05
|
|
|
CDG1A
|
[NCBI]
|
1.61701e-05
|
|
|
breast cancer
|
[NCBI]
|
1.61701e-05
|
|
|
GFAP
|
[NCBI]
|
1.57479e-05
|
|
|
C3
|
[NCBI]
|
1.57299e-05
|
|
|
COG1
|
[NCBI]
|
1.56065e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.56065e-05
|
|
|
RUVBL2
|
[NCBI]
|
1.56065e-05
|
|
|
ZNF385
|
[NCBI]
|
1.56065e-05
|
|
|
CDC42EP3
|
[NCBI]
|
1.56065e-05
|
|
|
EPB41L3
|
[NCBI]
|
1.56065e-05
|
|
|
PLEKHB1
|
[NCBI]
|
1.56065e-05
|
|
|
r binder protein
|
[NCBI]
|
1.56065e-05
|
|
|
PLEKHA1
|
[NCBI]
|
1.56065e-05
|
|
|
PABPC3
|
[NCBI]
|
1.56065e-05
|
|
|
CENTB2
|
[NCBI]
|
1.56065e-05
|
|
|
skap55-related protein
|
[NCBI]
|
1.56065e-05
|
|
|
PHLDB2
|
[NCBI]
|
1.56065e-05
|
|
|
ABTB1
|
[NCBI]
|
1.56065e-05
|
|
|
TOX3
|
[NCBI]
|
1.56065e-05
|
|
|
SDPR
|
[NCBI]
|
1.56065e-05
|
|
|
LANCL1
|
[NCBI]
|
1.56065e-05
|
|
|
PABPC4
|
[NCBI]
|
1.56065e-05
|
|
|
MAEA
|
[NCBI]
|
1.56065e-05
|
|
|
APCS
|
[NCBI]
|
1.52864e-05
|
|
|
NP
|
[NCBI]
|
1.46528e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.41373e-05
|
|
|
AFM
|
[NCBI]
|
1.38308e-05
|
|
|
MYLIP
|
[NCBI]
|
1.38308e-05
|
|
|
PTPN3
|
[NCBI]
|
1.38308e-05
|
|
|
UBE2V2
|
[NCBI]
|
1.38308e-05
|
|
|
ATF5
|
[NCBI]
|
1.38308e-05
|
|
|
SPTBN4
|
[NCBI]
|
1.38308e-05
|
|
|
ca(2+)-promoted ras inactivator
|
[NCBI]
|
1.38308e-05
|
|
|
TRIO
|
[NCBI]
|
1.38308e-05
|
|
|
TGM5
|
[NCBI]
|
1.38308e-05
|
|
|
PLCD1
|
[NCBI]
|
1.38308e-05
|
|
|
AOC3
|
[NCBI]
|
1.38308e-05
|
|
|
kindlin 1
|
[NCBI]
|
1.38308e-05
|
|
|
PRKCM
|
[NCBI]
|
1.3761e-05
|
|
|
IP
|
[NCBI]
|
1.32734e-05
|
|
|
CFH
|
[NCBI]
|
1.32398e-05
|
|
|
GDNF
|
[NCBI]
|
1.27957e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.26428e-05
|
|
|
HAE
|
[NCBI]
|
1.26428e-05
|
|
|
MRC1
|
[NCBI]
|
1.25217e-05
|
|
|
FAF1
|
[NCBI]
|
1.25217e-05
|
|
|
VTCN1
|
[NCBI]
|
1.25217e-05
|
|
|
SH2B3
|
[NCBI]
|
1.25217e-05
|
|
|
RABGAP1L
|
[NCBI]
|
1.25217e-05
|
|
|
NPHS2
|
[NCBI]
|
1.25217e-05
|
|
|
MASP2
|
[NCBI]
|
1.25217e-05
|
|
|
PHLDA2
|
[NCBI]
|
1.25217e-05
|
|
|
HPX
|
[NCBI]
|
1.21634e-05
|
|
|
CFI
|
[NCBI]
|
1.18875e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.17945e-05
|
|
|
galactosemia
|
[NCBI]
|
1.1756e-05
|
|
|
COMT
|
[NCBI]
|
1.17316e-05
|
|
|
GSN
|
[NCBI]
|
1.16208e-05
|
|
|
APOH
|
[NCBI]
|
1.16208e-05
|
|
|
ERMAP
|
[NCBI]
|
1.14874e-05
|
|
|
ABCB7
|
[NCBI]
|
1.14874e-05
|
|
|
VAV3
|
[NCBI]
|
1.14874e-05
|
|
|
EPS15
|
[NCBI]
|
1.14874e-05
|
|
|
CPB1
|
[NCBI]
|
1.14874e-05
|
|
|
HAX1
|
[NCBI]
|
1.14874e-05
|
|
|
RBM8A
|
[NCBI]
|
1.14874e-05
|
|
|
LTB
|
[NCBI]
|
1.14874e-05
|
|
|
NEGF2
|
[NCBI]
|
1.14874e-05
|
|
|
GPRK2L
|
[NCBI]
|
1.14874e-05
|
|
|
DGKD
|
[NCBI]
|
1.14874e-05
|
|
|
CALU
|
[NCBI]
|
1.14874e-05
|
|
|
SLC9A3R1
|
[NCBI]
|
1.14874e-05
|
|
|
PLUNC
|
[NCBI]
|
1.14874e-05
|
|
|
ABL
|
[NCBI]
|
1.1475e-05
|
|
|
FOXO1A
|
[NCBI]
|
1.11133e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.11126e-05
|
|
|
IBD1
|
[NCBI]
|
1.09335e-05
|
|
|
SLE
|
[NCBI]
|
1.08863e-05
|
|
|
THBS2
|
[NCBI]
|
1.06346e-05
|
|
|
AKAP13
|
[NCBI]
|
1.06346e-05
|
|
|
ADD2
|
[NCBI]
|
1.06346e-05
|
|
|
WNT11
|
[NCBI]
|
1.06346e-05
|
|
|
S100A12
|
[NCBI]
|
1.06346e-05
|
|
|
LGALS3BP
|
[NCBI]
|
1.06346e-05
|
|
|
ANK3
|
[NCBI]
|
1.06346e-05
|
|
|
GIP
|
[NCBI]
|
1.05979e-05
|
|
|
OCP
|
[NCBI]
|
1.04178e-05
|
|
|
FY
|
[NCBI]
|
1.01893e-05
|
|
|
BCGF
|
[NCBI]
|
1.01691e-05
|
|
|
SLC9A1
|
[NCBI]
|
9.91091e-06
|
|
|
STC2
|
[NCBI]
|
9.91091e-06
|
|
|
MICB
|
[NCBI]
|
9.91091e-06
|
|
|
GOPC
|
[NCBI]
|
9.91091e-06
|
|
|
DEFA3
|
[NCBI]
|
9.91091e-06
|
|
|
GPR77
|
[NCBI]
|
9.91091e-06
|
|
|
PAI2
|
[NCBI]
|
9.91091e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
9.68898e-06
|
|
|
FGF7
|
[NCBI]
|
9.68189e-06
|
|
|
PTK2
|
[NCBI]
|
9.45101e-06
|
|
|
ANGPTL3
|
[NCBI]
|
9.2837e-06
|
|
|
SLC30A4
|
[NCBI]
|
9.2837e-06
|
|
|
SLC9A3R2
|
[NCBI]
|
9.2837e-06
|
|
|
CHIT1
|
[NCBI]
|
9.2837e-06
|
|
|
NT5C3
|
[NCBI]
|
9.2837e-06
|
|
|
PRDX1
|
[NCBI]
|
9.2837e-06
|
|
|
PLCB2
|
[NCBI]
|
9.2837e-06
|
|
|
CRAT
|
[NCBI]
|
9.2837e-06
|
|
|
GAPDH
|
[NCBI]
|
9.11777e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
9.00953e-06
|
|
|
CGD
|
[NCBI]
|
8.79326e-06
|
|
|
PBK
|
[NCBI]
|
8.73138e-06
|
|
|
AZGP1
|
[NCBI]
|
8.73138e-06
|
|
|
CXCL9
|
[NCBI]
|
8.73138e-06
|
|
|
FBLN1
|
[NCBI]
|
8.73138e-06
|
|
|
FGD1
|
[NCBI]
|
8.73138e-06
|
|
|
PSCD2
|
[NCBI]
|
8.73138e-06
|
|
|
SOS1
|
[NCBI]
|
8.73138e-06
|
|
|
Ss
|
[NCBI]
|
8.2389e-06
|
|
|
ATSV
|
[NCBI]
|
8.2389e-06
|
|
|
PDPK1
|
[NCBI]
|
8.2389e-06
|
|
|
CD55
|
[NCBI]
|
8.2389e-06
|
|
|
HCF2
|
[NCBI]
|
8.2389e-06
|
|
|
DSTN
|
[NCBI]
|
8.12627e-06
|
|
|
HGF
|
[NCBI]
|
7.85474e-06
|
|
|
PPARA
|
[NCBI]
|
7.80897e-06
|
|
|
DNM2
|
[NCBI]
|
7.79532e-06
|
|
|
CFD
|
[NCBI]
|
7.79532e-06
|
|
|
MSN
|
[NCBI]
|
7.79532e-06
|
|
|
flaujeac factor deficiency
|
[NCBI]
|
7.79532e-06
|
|
|
EIF2S1
|
[NCBI]
|
7.39247e-06
|
|
|
NCF2
|
[NCBI]
|
7.39247e-06
|
|
|
CNTFR
|
[NCBI]
|
7.39247e-06
|
|
|
F13B
|
[NCBI]
|
7.02405e-06
|
|
|
DUOX2
|
[NCBI]
|
7.02405e-06
|
|
|
MTMR2
|
[NCBI]
|
7.02405e-06
|
|
|
F3
|
[NCBI]
|
6.92614e-06
|
|
|
ADA
|
[NCBI]
|
6.91383e-06
|
|
|
ATF3
|
[NCBI]
|
6.81154e-06
|
|
|
SCGF
|
[NCBI]
|
6.68514e-06
|
|
|
SCCA1
|
[NCBI]
|
6.68514e-06
|
|
|
TBXA2R
|
[NCBI]
|
6.68514e-06
|
|
|
ART4
|
[NCBI]
|
6.68514e-06
|
|
|
KLF1
|
[NCBI]
|
6.68127e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
6.55155e-06
|
|
|
LPI
|
[NCBI]
|
6.37869e-06
|
|
|
LU
|
[NCBI]
|
6.37179e-06
|
|
|
C4BPA
|
[NCBI]
|
6.37179e-06
|
|
|
TLR4
|
[NCBI]
|
6.275e-06
|
|
|
PTHLH
|
[NCBI]
|
6.22058e-06
|
|
|
ATRN
|
[NCBI]
|
6.0808e-06
|
|
|
NPHS1
|
[NCBI]
|
6.0808e-06
|
|
|
PDCD1
|
[NCBI]
|
6.0808e-06
|
|
|
ATF1
|
[NCBI]
|
6.0808e-06
|
|
|
CYP2C9
|
[NCBI]
|
6.0808e-06
|
|
|
DBA
|
[NCBI]
|
5.9116e-06
|
|
|
OSM
|
[NCBI]
|
5.87472e-06
|
|
|
von willebrand disease
|
[NCBI]
|
5.84238e-06
|
|
|
NFKBIA
|
[NCBI]
|
5.80953e-06
|
|
|
DLL1
|
[NCBI]
|
5.80953e-06
|
|
|
VIL2
|
[NCBI]
|
5.80953e-06
|
|
|
APOA4
|
[NCBI]
|
5.80953e-06
|
|
|
KEL
|
[NCBI]
|
5.55579e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
5.41483e-06
|
|
|
FRAP1
|
[NCBI]
|
5.38852e-06
|
|
|
FRDA
|
[NCBI]
|
5.33319e-06
|
|
|
LMX1B
|
[NCBI]
|
5.31773e-06
|
|
|
PGM3
|
[NCBI]
|
5.31773e-06
|
|
|
LGALS3
|
[NCBI]
|
5.31773e-06
|
|
|
LCN2
|
[NCBI]
|
5.31301e-06
|
|
|
SLC6A4
|
[NCBI]
|
5.26962e-06
|
|
|
SHBG
|
[NCBI]
|
5.17817e-06
|
|
|
RETN
|
[NCBI]
|
5.09379e-06
|
|
|
DLL4
|
[NCBI]
|
5.09379e-06
|
|
|
PMCH
|
[NCBI]
|
4.91359e-06
|
|
|
CLCN5
|
[NCBI]
|
4.8826e-06
|
|
|
GJA1
|
[NCBI]
|
4.82546e-06
|
|
|
AHO
|
[NCBI]
|
4.80143e-06
|
|
|
HBA1
|
[NCBI]
|
4.79617e-06
|
|
|
CR1
|
[NCBI]
|
4.68302e-06
|
|
|
NNMT
|
[NCBI]
|
4.68302e-06
|
|
|
EBF
|
[NCBI]
|
4.68302e-06
|
|
|
wilson disease
|
[NCBI]
|
4.55178e-06
|
|
|
XK
|
[NCBI]
|
4.49404e-06
|
|
|
RPS19
|
[NCBI]
|
4.49404e-06
|
|
|
PINK1
|
[NCBI]
|
4.49404e-06
|
|
|
EGR2
|
[NCBI]
|
4.49404e-06
|
|
|
TMOD
|
[NCBI]
|
4.49404e-06
|
|
|
RHD
|
[NCBI]
|
4.49404e-06
|
|
|
LRP1
|
[NCBI]
|
4.44784e-06
|
|
|
MBL2
|
[NCBI]
|
4.44784e-06
|
|
|
IGFALS
|
[NCBI]
|
4.39089e-06
|
|
|
LDLR
|
[NCBI]
|
4.2475e-06
|
|
|
G6PD
|
[NCBI]
|
4.23555e-06
|
|
|
CD59
|
[NCBI]
|
4.14442e-06
|
|
|
GLO1
|
[NCBI]
|
3.98232e-06
|
|
|
TFPI
|
[NCBI]
|
3.94169e-06
|
|
|
ATF6
|
[NCBI]
|
3.82786e-06
|
|
|
CREB1
|
[NCBI]
|
3.82786e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.75577e-06
|
|
|
INPP5D
|
[NCBI]
|
3.68048e-06
|
|
|
ELA2
|
[NCBI]
|
3.68048e-06
|
|
|
LDHB
|
[NCBI]
|
3.68048e-06
|
|
|
PPIB
|
[NCBI]
|
3.5397e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
3.44877e-06
|
|
|
COL4A3
|
[NCBI]
|
3.40508e-06
|
|
|
C1NH
|
[NCBI]
|
3.40508e-06
|
|
|
ATF4
|
[NCBI]
|
3.40508e-06
|
|
|
NR1I2
|
[NCBI]
|
3.30755e-06
|
|
|
HSCR1
|
[NCBI]
|
3.16057e-06
|
|
|
CD2AP
|
[NCBI]
|
3.15277e-06
|
|
|
IRS2
|
[NCBI]
|
3.15277e-06
|
|
|
CDKN1B
|
[NCBI]
|
3.15277e-06
|
|
|
MAP2
|
[NCBI]
|
3.12156e-06
|
|
|
IGKC
|
[NCBI]
|
3.03439e-06
|
|
|
MN
|
[NCBI]
|
2.92078e-06
|
|
|
SRF
|
[NCBI]
|
2.9067e-06
|
|
|
LCAT
|
[NCBI]
|
2.84742e-06
|
|
|
INS
|
[NCBI]
|
2.74998e-06
|
|
|
AK1
|
[NCBI]
|
2.70682e-06
|
|
|
ABCC6
|
[NCBI]
|
2.70682e-06
|
|
|
CXCL12
|
[NCBI]
|
2.70682e-06
|
|
|
TIMP1
|
[NCBI]
|
2.70682e-06
|
|
|
ABCC2
|
[NCBI]
|
2.64776e-06
|
|
|
PIGA
|
[NCBI]
|
2.60599e-06
|
|
|
ICAM1
|
[NCBI]
|
2.60599e-06
|
|
|
MICA
|
[NCBI]
|
2.60599e-06
|
|
|
CDK5
|
[NCBI]
|
2.45667e-06
|
|
|
CXCR4
|
[NCBI]
|
2.41556e-06
|
|
|
KSS
|
[NCBI]
|
2.39889e-06
|
|
|
CDK2
|
[NCBI]
|
2.38281e-06
|
|
|
SPP1
|
[NCBI]
|
2.24687e-06
|
|
|
ADIPOQ
|
[NCBI]
|
2.15528e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
2.15528e-06
|
|
|
TACR1
|
[NCBI]
|
2.15528e-06
|
|
|
MST1
|
[NCBI]
|
1.99685e-06
|
|
|
PEPD
|
[NCBI]
|
1.99685e-06
|
|
|
TSC1
|
[NCBI]
|
1.99685e-06
|
|
|
SLC16A1
|
[NCBI]
|
1.92176e-06
|
|
|
XDH
|
[NCBI]
|
1.79697e-06
|
|
|
PPIA
|
[NCBI]
|
1.77552e-06
|
|
|
OXT
|
[NCBI]
|
1.74849e-06
|
|
|
TS
|
[NCBI]
|
1.68721e-06
|
|
|
C4A
|
[NCBI]
|
1.64619e-06
|
|
|
TPT1
|
[NCBI]
|
1.583e-06
|
|
|
GSR
|
[NCBI]
|
1.52191e-06
|
|
|
AKT1
|
[NCBI]
|
1.52191e-06
|
|
|
NF2
|
[NCBI]
|
1.52191e-06
|
|
|
CD47
|
[NCBI]
|
1.52191e-06
|
|
|
CVID
|
[NCBI]
|
1.44015e-06
|
|
|
ILK
|
[NCBI]
|
1.33943e-06
|
|
|
PEDF
|
[NCBI]
|
1.29841e-06
|
|
|
PGM1
|
[NCBI]
|
1.29701e-06
|
|
|
ALAD
|
[NCBI]
|
1.29701e-06
|
|
|
ALK
|
[NCBI]
|
1.25781e-06
|
|
|
JAK2
|
[NCBI]
|
1.21763e-06
|
|
|
REN
|
[NCBI]
|
1.14685e-06
|
|
|
F13A1
|
[NCBI]
|
1.1e-06
|
|
|
DMD
|
[NCBI]
|
9.85693e-07
|
|
|
SPTA1
|
[NCBI]
|
9.27248e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.09142e-07
|
|
|
PLG
|
[NCBI]
|
9.02107e-07
|
|
|
SLPI
|
[NCBI]
|
9.01213e-07
|
|
|
GPI
|
[NCBI]
|
8.88989e-07
|
|
|
IGF1
|
[NCBI]
|
8.87492e-07
|
|
|
GRB2
|
[NCBI]
|
8.87492e-07
|
|
|
ACE
|
[NCBI]
|
8.8182e-07
|
|
|
APP
|
[NCBI]
|
6.38972e-07
|
|
|
HEMB
|
[NCBI]
|
5.91711e-07
|
|
|
IL6
|
[NCBI]
|
5.45807e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.23943e-07
|
|
|
CD36
|
[NCBI]
|
5.00814e-07
|
|
|
ANG
|
[NCBI]
|
4.75187e-07
|
|
|
RA
|
[NCBI]
|
4.73925e-07
|
|
|
SNCA
|
[NCBI]
|
4.26587e-07
|
|
|
AVP
|
[NCBI]
|
4.16109e-07
|
|
|
AGER
|
[NCBI]
|
4.03187e-07
|
|
|
AIS
|
[NCBI]
|
3.80915e-07
|
|
|
MTR
|
[NCBI]
|
2.64508e-07
|
|
|
NPPA
|
[NCBI]
|
2.35607e-07
|
|
|
LEP
|
[NCBI]
|
2.33277e-07
|
|
|
GPT
|
[NCBI]
|
2.31329e-07
|
|
|
CCL17
|
[NCBI]
|
2.31329e-07
|
|
|
PTK2B
|
[NCBI]
|
2.31329e-07
|
|
|
FGF2
|
[NCBI]
|
2.22604e-07
|
|
|
PON1
|
[NCBI]
|
2.12139e-07
|
|
|
HLA-A
|
[NCBI]
|
2.00826e-07
|
|
|
TNC
|
[NCBI]
|
1.63028e-07
|
|
|
SOD1
|
[NCBI]
|
1.50658e-07
|
|
|
KDR
|
[NCBI]
|
1.44935e-07
|
|
|
PABPC1
|
[NCBI]
|
1.35533e-07
|
|
|
APOB
|
[NCBI]
|
1.3059e-07
|
|
|
LPL
|
[NCBI]
|
1.28778e-07
|
|
|
PTEN
|
[NCBI]
|
1.27765e-07
|
|
|
RTT
|
[NCBI]
|
1.18567e-07
|
|
|
CCL22
|
[NCBI]
|
1.1353e-07
|
|
|
HBA2
|
[NCBI]
|
1.03791e-07
|
|
|
RB1
|
[NCBI]
|
8.90347e-08
|
|
|
MODY
|
[NCBI]
|
6.81257e-08
|
|
|
MYOC
|
[NCBI]
|
5.3355e-08
|
|
|
RP
|
[NCBI]
|
3.12813e-08
|
|
|
CPB2
|
[NCBI]
|
2.07023e-08
|
|
|
homocystinuria
|
[NCBI]
|
1.33518e-08
|
|
|
RASA1
|
[NCBI]
|
5.19504e-09
|
|
|
ABP1
|
[NCBI]
|
4.26178e-09
|
|
|
BCHE
|
[NCBI]
|
1.07713e-09
|
|
|
PC
|
[NCBI]
|
6.35497e-11
|
|